Skip to Main Content

Author Details

Ling-Yuan Kong
The University of Texas MD Anderson Cancer Center
1994
78
39
PMIDPaper TitleJournal TitlePublished Year
36759517FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.Nat Commun2023
36831427A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.Cancers (Basel)2023
36001588In-hospital outcomes of SARS-CoV-2-infected health care workers in the COVID-19 pandemic first wave, Quebec, Canada.PLoS One2022
34110743Utility of Whole Genome Sequencing in Assessing and Enhancing Partner Notification of Neisseria gonorrhoeae Infection.Sex Transm Dis2021
33571109Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme.Sci Adv2021
34910717A 57-Year-Old Man with Type 1 Diabetes Mellitus and a Chronic Foot Ulcer Successfully Managed with a Remote Patient-Facing Wound Care Smartphone Application.Am J Case Rep2021
34272314Contribution of AMPA Receptor-Mediated LTD in LA/BLA-CeA Pathway to Comorbid Aversive and Depressive Symptoms in Neuropathic Pain.J Neurosci2021
34031054Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.Clin Cancer Res2021
34257090Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.CMAJ Open2021
31633561Foodborne transmission of Clostridioides difficile: a review.Curr Opin Gastroenterol2020
34240055Prolonged empirical antibiotic therapy is correlated with bloodstream infections and increased mortality in a tertiary care hospital in Ethiopia: bacteriology testing matters.JAC Antimicrob Resist2020
31873309Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.Nat Med2020
33348707MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme.Cancers (Basel)2020
32605912Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy.Clin Cancer Res2020
32721947Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.JCI Insight2020
32554515Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.Clin Cancer Res2020
30307407Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.J Clin Invest2019
29846557Clostridium difficile: Investigating Transmission Patterns Between Infected and Colonized Patients Using Whole Genome Sequencing.Clin Infect Dis2019
29947810The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.J Natl Cancer Inst2019
31201853The perils of PCR-based diagnosis of Clostridioides difficile infections: Painful lessons from clinical trials.Anaerobe2019
29307707Travel-Related Infections Among Pregnant Travellers to the Tropics: An Overview.J Obstet Gynaecol Can2018
29991446Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.Cancer Lett2018
29636332Intradermal pre-exposure rabies vaccination in a Canadian travel clinic: 6-year retrospective observational study.CMAJ Open2018
29540433Understanding Clostridium difficile Colonization.Clin Microbiol Rev2018
27765835Immune modulatory nanoparticle therapeutics for intracerebral glioma.Neuro Oncol2017
28792883Left-Middle-Lobe Pneumonia.N Engl J Med2017
27713131Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells.Oncotarget2016
26658052MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.Neuro Oncol2016
26323609PD-L1 expression and prognostic impact in glioblastoma.Neuro Oncol2016
25525055Rapid progression to gummatous syphilitic hepatitis and neurosyphilis in a patient with newly-diagnosed HIV.Int J STD AIDS2015
26422086Bacteremia caused by a mecA-positive oxacillin-susceptible Staphylococcus aureus strain with inducible resistance.Diagn Microbiol Infect Dis2015
27467917Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression.Oncoimmunology2015
25971300FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.J Natl Cancer Inst2015
25728150Predictors of asymptomatic Clostridium difficile colonization on hospital admission.Am J Infect Control2015
24938283Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy.Cancer Immunol Res2014
25465288Therapeutic targets in subependymoma.J Neuroimmunol2014
24974128Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.J Natl Cancer Inst2014
23636127miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.Cancer Res2013
23876636Perspectives of family physicians on the care of uninsured pregnant women.J Obstet Gynaecol Can2013
21792892The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.Int J Cancer2012
23013619Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.Oncotarget2012
22753228Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.Neuro Oncol2012
22488042The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival.Oncotarget2012
21490182Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.Clin Cancer Res2011
21283755Hypoxia potentiates glioma-mediated immunosuppression.PLoS One2011
20053772Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.Mol Cancer Ther2010
20921210Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.Clin Cancer Res2010
20667896Glioma cancer stem cells induce immunosuppressive macrophages/microglia.Neuro Oncol2010
20388845Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.Clin Cancer Res2010
20068105Glioma-associated cancer-initiating cells induce immunosuppression.Clin Cancer Res2010
  • 1 - 50 of 78

Recommended Authors

College of Life Science and Engineering, Southwest Jiaotong University
Career Start Year 2015
Number of shared co-authors 0
Yale University
Career Start Year 2012
Number of shared co-authors 0
Henan University
Career Start Year 2010
Number of shared co-authors 0
Westlake University
Career Start Year 2009
Number of shared co-authors 0
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
University of Illinois College of Medicine Rockford
Career Start Year 2007
Number of shared co-authors 0
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
West China Hospital, Sichuan University
Career Start Year 2005
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 0
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2003
Number of shared co-authors 0
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2002
Number of shared co-authors 0
College of Medicine, The Catholic University of Korea
Career Start Year 2000
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Stomatology Hospital, Zhejiang University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Institute of Pathogens and Vectors, Dali University
Career Start Year 1998
Number of shared co-authors 1
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 0
Uniformed Services University of the Health Sciences
Career Start Year 1997
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Hangzhou First People's Hospital Affiliated to Zhejiang University
Career Start Year 1995
Number of shared co-authors 0
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year 1993
Number of shared co-authors 0
Korea University College of Medicine, Korea University Ansan Hospital
Career Start Year 1993
Number of shared co-authors 1
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 0
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 1
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 0
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 10
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 6
University Hospital Zurich
Career Start Year 1982
Number of shared co-authors 0
Heersink School of Medicine, The University of Alabama at Birmingham
Career Start Year 1970
Number of shared co-authors 1

Collaborators

Northwestern University Feinberg School of Medicine
Co-authored papers 39
The University of Texas MD Anderson Cancer Center
Co-authored papers 28
MD Anderson Cancer Center
Co-authored papers 22
The University of Texas MD Anderson Cancer Center
Co-authored papers 15
South China University of Technology
Co-authored papers 14
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 13
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers 10
Xuanwu Hospital, Capital Medical University
Co-authored papers 5
Baylor College of Medicine, The University of Texas MD Anderson Cancer Center
Co-authored papers 5
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Co-authored papers 4
University of Michigan Rogel Cancer Center.
Co-authored papers 3
Baylor College of Medicine
Co-authored papers 3
Huntsman Cancer Institute, University of Utah
Co-authored papers 2
The MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Co-authored papers 2
NYU Grossman School of Medicine
Co-authored papers 2
Co-authored papers 2
Northwestern University
Co-authored papers 1
School of Medicine and Pharmacy, Ocean University of China
Co-authored papers 1
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 1
Virginia Commonwealth University
Co-authored papers 1
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers 1
Hopital Universitaire Necker-Enfants Malades
Co-authored papers 1
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Co-authored papers 1